BioLineRx Ltd. (BLRX)
3.10
-0.11 (-3.43%)
At close: Mar 13, 2025, 3:59 PM
3.18
2.58%
After-hours: Mar 13, 2025, 04:39 PM EDT
BioLineRx Ltd. Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 4.25M | 10.59M | 12.99M | 16.83M | 5.3M | 3.4M | 5.11M | 2.47M | 5.54M | 5.78M | 8.87M | 18.29M | 8.69M |
| Short-Term Investments | 38.74M | 40.49M | 44.15M | 5.76M | 22.19M | 26.75M | 44.37M | 33.15M | 42.12M | 28.85M | 9.29M | 3.07M | 17.28M |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 1M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | 56K | 61K | 52K | 58K | 214.18K | 213.07K | 994.93K | 775.09K |
| Receivables | 708K | 721K | 142K | 141K | 613K | 1.34M | 586K | n/a | 291K | 257K | 360K | n/a | 1M |
| Inventory | 1.95M | -41.22M | n/a | n/a | n/a | n/a | -44.07M | n/a | -41.89M | -36.21K | -0.00 | 2.00 | n/a |
| Other Current Assets | 1.53M | 198K | 127K | 152K | 108K | 488K | 307K | 255K | 229K | 221K | 258K | 216.03K | 180.5K |
| Total Current Assets | 47.18M | 52M | 57.4M | 22.88M | 28.21M | 31.98M | 50.38M | 36.1M | 48.18M | 35.11M | 18.77M | 22.18M | 27.16M |
| Property-Plant & Equipment | 1.89M | 2.5M | 2.28M | 2.7M | 3.47M | 2.23M | 2.5M | 2.6M | 2.91M | 720.1K | 709.55K | 849.05K | 1.11M |
| Goodwill & Intangibles | 14.85M | 21.89M | 21.7M | 21.71M | 21.89M | 21.97M | 7.02M | 181K | 152K | 117.36K | 252.12K | 284.53K | 300.58K |
| Total Long-Term Assets | 16.74M | 24.38M | 23.99M | 24.41M | 25.36M | 24.25M | 10.59M | 2.84M | 3.12M | 1.05M | 1.17M | 2.13M | 2.18M |
| Total Assets | 63.92M | 76.38M | 81.39M | 47.29M | 53.57M | 56.23M | 60.97M | 38.94M | 51.3M | 36.17M | 19.95M | 24.31M | 29.34M |
| Account Payables | 10.87M | 6.97M | 5.57M | 5.92M | 7.79M | 4.49M | 5.52M | 2.59M | 1.91M | 1.65M | 2.29M | 3.29M | 2.96M |
| Deferred Revenue | 12.96M | n/a | n/a | n/a | 1.27M | n/a | 1.09M | 963K | 1.13M | n/a | n/a | 683.63K | 1.64M |
| Short-Term Debt | 3.67M | 2.4M | 2.92M | 3.28M | 2.89M | 895K | 93K | 93K | 93K | n/a | n/a | 36.67K | -3.37M |
| Other Current Liabilities | 3.35M | 1.32M | 1.23M | 1.44M | 1.28M | 1.36M | 1.11M | 978K | 1.14M | 1.25M | 764K | 3.11M | 2.04M |
| Total Current Liabilities | 30.85M | 10.68M | 9.72M | 10.64M | 11.97M | 6.75M | 6.72M | 3.66M | 3.14M | 2.9M | 3M | 6.43M | 6.75M |
| Long-Term Debt | 7.92M | 10.36M | 1.73M | 4.4M | 7.56M | 7.84M | 157K | 250K | 344K | n/a | n/a | n/a | 28.9K |
| Other Long-Term Liabilities | 11.93M | 4.51M | 1.86M | 10.22M | 658K | 323K | 1.21M | 1K | 208K | 1.5M | 5.27M | 2.91M | 21.81K |
| Total Long-Term Liabilities | 19.85M | 14.86M | 3.58M | 14.62M | 8.22M | 8.16M | 1.36M | 251K | 552K | 1.5M | 5.27M | 2.91M | 50.71K |
| Total Liabilities | 50.7M | 25.54M | 13.3M | 25.26M | 20.19M | 14.91M | 8.08M | 3.91M | 3.69M | 4.4M | 8.27M | 9.34M | 6.81M |
| Total Debt | 11.59M | 12.32M | 4.65M | 7.68M | 10.46M | 8.73M | 250K | 343K | 437K | n/a | n/a | 36.67K | 109.56K |
| Common Stock | 31.36M | 27.1M | 21.07M | 9.87M | 4.69M | 3.11M | 2.84M | 1.51M | 1.46M | 1M | 693.18K | 491.71K | 324.75K |
| Retained Earnings | -390.61M | -329.99M | -305.04M | -277.99M | -247.97M | -222.52M | -199.56M | -175.21M | -159.37M | -140.06M | -145.23M | -118.94M | -96.71M |
| Comprehensive Income | 16.99M | 13.35M | 11.74M | 10.91M | 10.72M | 10.54M | 8.92M | 9.15M | 9.32M | 9.37M | 9.82M | 9.05M | -2M |
| Shareholders Equity | 13.22M | 50.84M | 68.09M | 22.03M | 33.38M | 41.32M | 52.88M | 35.03M | 47.61M | 31.77M | 11.68M | 14.97M | 22.53M |
| Total Investments | 38.74M | 40.49M | 44.15M | 5.76M | 22.19M | 26.75M | 45.37M | 33.15M | 42.12M | 28.85M | 9.29M | 3.07M | 17.28M |